Abrocitinib With Topical Therapy in Adolescents With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial
JAMA Dermatol 2021 Aug 18;[EPub Ahead of Print], LF Eichenfield, C Flohr, R Sidbury, E Siegfried, Z Szalai, R Galus, Z Yao, H Takahashi, S Barbarot, C Feeney, F Zhang, M DiBonaventura, R Rojo, H Valdez, G ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.